HealthEcon in Switzerland published a very interesting book (so far in German only) on experiences with HTA agencies in these three countries. The author - Rainer Rohrbacher - concludes that these types of government interventions have not lead to the desired impact on drug spending nor improved the quality of provision with medicines in these centralized healthcare systems...
11.16.2007
Cost-benefit evaluations of drugs as an instrument of health policy - new insights from Australia, Canada and the UK
HealthEcon in Switzerland published a very interesting book (so far in German only) on experiences with HTA agencies in these three countries. The author - Rainer Rohrbacher - concludes that these types of government interventions have not lead to the desired impact on drug spending nor improved the quality of provision with medicines in these centralized healthcare systems...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment